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EDITORIAL
Potential role for G-protein coupled receptors in HIV-associated
nephropathy
The discovery that members of the chemokine receptor
family act as necessary co-receptors for entry of human
immunodeficiency virus-i (HIV-1) into susceptible cells
has provided major insights into the determinants of cellu-
lar tropism. Variations in the ability of certain Strains to
replicate in different CD4+ cells can now be explained by
unique interactions between the viral envelope and any one
of a number of co-receptors expressed on different CD4+
cells. Viral strains previously characterized as predomi-
nantly T-tropic and with the capability of replicating in
tumor derived T-cell lines utilize the CXCR4 receptor,
while macrophage-tropic isolates primarily use CCR-5 [1].
At least ninc additional chemokine receptor-like molecules
have now been demonstrated to be capable of acting as
co-receptors for HIV using in vitro assays; however, the role
of many of these additional coreceptors in vivo remains
unclear, as the majority of primary isolates have been
shown to use CXCR4, CCR5 and CCR3 alone or in
combination [2J. Tissue specific selective expression of
these co-receptors most like'y plays a role in determining
tissue tropism in. tivo, thus potentially influencing different
disease manifestations.
Furthermore, genetic polymorphism of either the che-
mokine receptors or their ligands has provided insight into
the genetic determinants of infection as well as disease
progression. Individuals homozygous for a deletion in one
of the coreceptors, CCR5, are rarely infected with HIV-1.
Interestingly, this deletion is predominantly found in those
of Northern European descent [3J. HIV-infected people
displaying a stow disease progression have been found to
have one or more genetic polymorphisms including het-
erozygous deletion of CCR5, polymorphism in an alterna-
tive coreceptor CCR2b or in the CXCR4 receptor ligand,
SDF-1 [4, 5J. HIV-associated nephropathy (HIVAN) is a
unique tissue manifestation of infection with a striking
predominance in African Americans [6). A full evaluation
of the renal expression of HIV-1 co-receptors as well as
viral strain utilization of these coreceptors in individuals
with this manifestation might shed light on both the
pathogenesis as well as genetic determinants of HIVAI'J.
FILVAN, like HIV-associated central nervous system
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(CNS) disease, is a relatively late complication, develops in
only a subset of individuals infected with the virus, and to
date appears to be a direct complication of the virus,
although the role of a cofactor(s) cannot be excluded. The
direct demonstration of the virus has been more convinc-
ingly demonstrated in primary CNS cells, particularly mi-
croglial cells. Direct infection of primary renal cells in vitro
and in viyo has been probkmatic to date, although it is
always difficult to exclude technical difficulties as well as
the limitations of in vüro systems. In studies directed at
determining the role of coreceptor specificity in CNS
disease, several of these coreceptors have been shown to
facilitate infection of cells derived from the CNS, although
there is not a full understanding of how this selective
expression determines the development of HI V-associated
CNS complications in certain individuals. CCR5 and pos-
sibly CCR3 can act as coreceptors in the presence of CD4
for microglia, one of the major targets for CNS infection.
Interestingly, some of the more recently described co-
receptors, including STRL33 and TERI/CCR8, are ex-
pressed in brain-derived cells; however, their specific role
in determining infection of the central nervous system
remains unclear [7]. The SIV/macaque model has provided
some interesting insights into the potential role of these
coreceptors in CNS disease that may have implications for
HIV-1. Brain capillary endothelial cells from rhesus ma-
caques express the co-receptors CCR5, CCR3, CXCR4 and
STRL33, and can be infected by a particularly neuroviru-
lent strain of SlY. Furthermore, entry into these endothe-
hal cells using the co-receptor CCR5 appears to be
uniquely CD4-independent [8].
The issue of tissue-specific expression of H [V-I co-
receptors as one of the selective events in HIVAN is
appropriate to consider as well. The importance of this
issue does not necessarily depend on the direct demonstra-
tion of the virus in the kidney, as a circulating viral
envelope would be sufficient to bind to and induce signaling
through any one of these seven-transmembrane-spanning
G-protein coupled receptors. As a step in exploring a role
for these co-receptors in HIVAN, the article by Eitner et al
in this issue of KidneyInternational evaluates the expression
of CCR5 in human and primate kidneys in the presence
and absence of HIV or SIV infection [9]. Using in situ
hybridization, the authors did not detect CCR5-specific
mRNA in intrinsic renal cells of normal kidneys nor in
kidneys from HIV-1, HIV-2 or SIV-infected macaques.
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None of the kidneys from the lentivirus-infected animals
had patho'ogic features consistent with HIVAN. However,
ii human kidneys exhibiting a significant inflammatory
reaction as seen in ifltcrstitial nephritis and/or associated
with transplant rejection, CCR5 expression was detected
and appeared to be localized to either infiltrating mononu-
clear cells and/or endothelial or vascular smooth muscle
cells. The absence of expression of this co-receptor in
kidneys with no significant inflammatory process does not
exclude the role of this co-receptor in HIVAN, either
through direct infection of intrinsic renal cells or indirectly
through tissue infiltration with infected cells or viral prod-
ucts.
Expression of CCR5 in mononuclear-derived cells is
regulated by a number of stimuli including activation and
differentiation [10]. If expression of CCR5 on primary
renal cells was involved in HIVAN, it is possible that
cytokine stimulation is necessary as a prerequisite event,
and therefore examination of kidneys with early pathologic
features of HIVAN might provide further insight into the
role of this co-receptor. More intriguing is the possibility
that an alternative co-receptor, perhaps one that is infre-
quently expressed or for which there is considerable genetic
polymorphism, is involved in either entry of certain HIV-1
strains into renal tissue or binding to circulating envelope.
This would provide a potential explanation for the striking
predominance of this disease in blacks.
The pathogenesis of HIVAN remains an enigma. New
leads provided by the discovery of HIV co-receptors should
be vigorously pursued and may not only provide insights
iino pathogenesis, but provide new approaches to therapy
as well. A complete characterization of co-receptor expres-
sion in primary intrinsic renal cells under normal and
pathologic conditions, as well as further characterization of
viruses and viral envelopes derived from renal tissue of
individuals with this devastating manifestation, will be
necessary steps in this process.
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had path logic features consistent with HI VAN. How ver,
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The pathog nesis of HIVAN remains an enigma. New
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be vig rously pursued and may not only provide insights
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